Prague Med. Rep. 2020, 121, 114-117
https://doi.org/10.14712/23362936.2020.10
Life Threatening Delayed Complication of Botulinum Toxin Injection for Treatment of Spasmodic Dysphonia
References
1. , M., Morrison, M., Rammage, L., Lau, D. (2003) Selective denervation: Reinnervation for the control of adductor spasmodic dysphonia. J. Otolaryngol. 32(3), 185–189.
<https://doi.org/10.2310/7070.2003.40431>
2. , A., Brin, M., Simonyan, K., Ozelius, L. J., Frucht, S. J. (2018) Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience. Laryngoscope 128, 1–9.
<https://doi.org/10.1002/lary.27003>
3. , H. (1976) Recurrent laryngeal nerve section for spastic dysphonia. Ann. Otol. Rhinol. Laryngol. 85(4), 451–459.
<https://doi.org/10.1177/000348947608500405>
4. , B., Hammarberg, B., Schiratzki, H., Haglund, S., Knutsson, E., Martensson, A. (1993) Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia. J. Voice 7(2), 172–178.
<https://doi.org/10.1016/S0892-1997(05)80348-0>
5. , C. (2009) Treatment for spasmodic dysphonia: limitations of current approaches. Curr. Opin. Otolaryngol. Head Neck Surg. 17(3), 160–165.
<https://doi.org/10.1097/MOO.0b013e32832aef6f>
6. , T., Hu, A., Hillel, A. (2013) Voice disorders in the workplace: Productivity in spasmodic dysphonia and the impact of botulinum toxin. Laryngoscope 123, 1–14.
<https://doi.org/10.1002/lary.24292>
7. , J., Stone, R., Rainey, C., Zealear, D. L., Ossoff, R. H. (1991) Recurrent laryngeal nerve avulsion for treatment of spastic dysphonia. Ann. Otol. Rhinol. Laryngol. 100(1), 10–14.
<https://doi.org/10.1177/000348949110000102>
8. , D., Waters, H., D’Elia, J., Blitzer, A. (2011) Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes. Laryngoscope 121(3), 606–612.
<https://doi.org/10.1002/lary.21395>
9. , C., Lee, C., Hatcher, J., Michalek, J. (2016) Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: functional outcomes. Laryngoscope 126(1), 118–121.
<https://doi.org/10.1002/lary.25515>
10. , S., Saeseow, P., Taweesaengsuksakul, R., Kharmwan, S., Srirompotong, S. (2006) Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital. J. Med. Assoc. Thai. 89(12), 2077–2080.
11. , R., Robert, J., Francis, D., Schwartz, S. R., Damask, C. C., Digoy, G. P., Krouse, H. J., McCoy, S. J., Ouellette, D. R., Patel, R. R., Reavis, C. C. W., Smith, L. J., Smith, M., Strode, S. W., Woo, P., Nnacheta, L. C. (2018) Clinical practice guideline: hoarseness (dysphonia) (update). Otolaryngol. Head Neck Surg. 158, S1–S42 (Suppl. 1).
<https://doi.org/10.1177/0194599817751030>
12. , L. (2004) Contemporary management of spasmodic dysphonia. Curr. Opin. Otolaryngol. Head Neck Surg. 12(6), 543–548.
<https://doi.org/10.1097/01.moo.0000145959.50513.5e>
13. , L., Blitzer, A. (2004) Botulinum toxin treatment of spasmodic dysphonia. Oper. Tech. Otolaryngol. Head Neck Surg. 15(2), 76–80.
<https://doi.org/10.1016/j.otot.2004.02.007>
14. , H. (1989) Laryngeal framework surgery in the management of spasmodic dysphonia. Preliminary report. Ann. Otol. Rhinol. Laryngol. 98(1), 52–54.
<https://doi.org/10.1177/000348948909800111>
15. , N., Johns, M., Hapner, E., DelGaudio, J. (2010) Abductor paralysis after Botox injection for adductor spasmodic dysphonia. Laryngoscope 120(6), 1177–1180.
16. , P. (1990) Carbon dioxide laser-assisted thyroarytenoid myomectomy. Lasers Surg. Med. 10(5), 438–443.
<https://doi.org/10.1002/lsm.1900100507>
